MD Anderson Cancer Center
Houston, Texas, 77030, United States
Location status: Recruiting
Location contact
Ahmed Elsayem, MD,MPH
CONTACT
Ahmed Elsayem, MD,MPH
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06420206
To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Ahmed Elsayem, MD,MPH
CONTACT
Ahmed Elsayem, MD,MPH
PRINCIPAL_INVESTIGATOR
Primary Objective:
To compare overall percentage of days spent in an acute care setting over the 30-day period from time of the index emergency department (ED), referred to as Acute Cancer Care Center (ACCC), visit for patients who receive the emergency department-based GOC intervention and those who do not.
Secondary Objective:
To obtain data on rates of admission to the ICU, death in the hospital setting, symptom improvement for participants hospitalized, hospice referral, survival, and 30-day care costs for participants who receive the GOC intervention in the ACCC and those who do not.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In Group 1, participants will receive the usual standard of care by an emergency care physician not trained in palliative care.
In Group 2, participants will receive standard of care plus palliative care intervention by an emergency care physician trained in palliative care.
Time frame: through study completion; an average of 1 year
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04899908
AGuIX, Brain Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT02906943
Breast Cancer, Breast Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT07524114
Breast Cancer, Breast Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT07558447
Breast Cancer, Breast Diseases
Milan, Italy
View Trial Details